Substances
Buprenorphine vs. Suboxone: Which One is Right For You?
Medically Reviewed By
Written By
Last medically reviewed November 4, 2024
Substances
Medically Reviewed By
Written By
Last medically reviewed November 4, 2024
Making an informed choice between buprenorphine and Suboxone is a critical step in opioid dependence recovery, as these medication-assisted treatment options can be a vital part of the healing process. While both medications contain buprenorphine as their primary component, they have distinct features that can significantly impact your overall treatment success. Understanding these key differences will help you and your healthcare provider determine the most effective option for your long-term recovery.
Medication-assisted treatment (MAT) uses FDA-approved medications like methadone, buprenorphine, and naltrexone to treat opioid use disorder.[1] These substances work with your brain’s opioid receptors to normalize chemistry, block the euphoric effects of opioids, and reduce cravings without producing a high. MAT medications are prescribed alongside counseling and behavioral therapy, as addiction requires both physical and psychological treatment.
Research consistently shows MAT’s effectiveness, with studies demonstrating higher recovery rates than abstinence-only approaches.[2] Through taking prescribed MAT medications under medical supervision, patients can focus on recovery without the disruption of withdrawal symptoms and cravings. This medical stability creates a foundation for engaging in therapy and developing coping skills essential for long-term recovery.
Buprenorphine is a partial opioid agonist medication used to treat opioid use disorder.[3] As a partial agonist, it partially activates opioid receptors in the brain, helping to reduce withdrawal symptoms and cravings without producing the intense high of full opioids. Buprenorphine also has a ceiling effect – taking more won’t increase its effects beyond a certain point, which reduces abuse potential.[4]
The medication has several forms, including sublingual tablets and films that dissolve under the tongue. When prescribed alone (without naloxone), it’s typically used in supervised settings or during pregnancy, where naloxone exposure needs to be avoided. Buprenorphine requires careful medical supervision and dose adjustment to manage withdrawal symptoms while effectively preventing misuse.
Suboxone is a prescription medication that combines two drugs: buprenorphine and naloxone.[5] Buprenorphine helps manage opioid withdrawal symptoms and cravings, while naloxone acts as an abuse deterrent – if Suboxone is crushed and injected, the naloxone will trigger immediate withdrawal symptoms. Like plain buprenorphine, Suboxone comes in sublingual films and tablets.
The addition of naloxone makes Suboxone a preferred option for outpatient treatment since it has built-in protection against misuse. This allows qualified physicians to prescribe take-home doses, giving patients more flexibility in their treatment while maintaining safety.
While both medications contain buprenorphine for treating opioid dependence, several important distinctions between standalone buprenorphine and Suboxone can affect treatment choices:[6, 7]
While these medications are designed to treat opioid dependence, both can be misused despite their built-in safeguards.[8] Buprenorphine can be crushed and injected or snorted, which may produce euphoric effects by bypassing its intended sublingual delivery method. Even Suboxone, despite containing naloxone, can be misused by taking higher doses than prescribed or combining it with other substances like benzodiazepines. This dangerous practice can lead to severe respiratory depression.
Some people attempt to sell or trade these medications illegally or try to manipulate drug screenings to obtain extra doses. Withdrawal can still occur if either medication is stopped abruptly, and some individuals may attempt to self-adjust their dosage. These behaviors can lead to overdose, dangerous drug interactions, or legal consequences. This potential for misuse underscores why these medications require strict medical supervision, regular monitoring, prescription drug tracking, and clear treatment agreements between patients and healthcare providers.
Since buprenorphine is the primary active ingredient in both medications, they share similar side effects, which can include:[9]
More serious but less common side effects may include:[10]
It’s important to note that for most patients, the benefits of these medications far outweigh their potential side effects. Your healthcare provider will monitor you closely and can help manage any side effects that occur. Never adjust your dose or stop taking these medications without medical supervision, as this can lead to withdrawal symptoms.
The decision between buprenorphine and Suboxone should be made carefully with your healthcare provider, who will evaluate your specific situation and needs. They’ll consider factors like your treatment history, living situation, and insurance coverage to help determine the most appropriate medication. Your provider will also assess whether you need the additional safety features of Suboxone or if plain buprenorphine would be more suitable.
During your evaluation, be open with your healthcare team about your concerns, past experiences with treatment, and current circumstances. This information helps them create a treatment plan that fits your lifestyle and gives you the best chance of success. Remember that what works well for one person may not be ideal for another, and your provider’s goal is to find the right medication and approach for your recovery journey.
If you’re struggling with opioid use, taking the first step toward recovery can feel overwhelming, but there are many paths to healing and professionals ready to help. Start by contacting your doctor, calling SAMHSA’s 24/7 helpline (1-800-662-4357), or contacting an addiction treatment center. These professionals can assess your situation and help you understand your treatment options, including medical detox, medication-assisted treatment (MAT), counseling, and support groups.
Many people begin their recovery journey with medically supervised detox, which helps manage withdrawal symptoms safely and comfortably. From there, your healthcare team can help you transition into a comprehensive treatment program that includes MAT, individual therapy, group counseling, and other support services. Treatment can be designed specifically to your needs, whether that means intensive outpatient programs that allow you to maintain work and family responsibilities or residential treatment for more structured support.
Treatment duration varies significantly for each person and depends on multiple factors, including your recovery progress, stability, and support system. While some people may stay on these medications for months, others might need years of treatment. There’s no “right” length of time – the goal is to maintain stability in your recovery. Your healthcare provider will work with you to determine when and if tapering off medication is appropriate based on your circumstances and progress.
If you miss a dose, take it as soon as you remember unless it’s almost time for your next scheduled dose. Never take a double dose to compensate for a missed one, as this can be dangerous. Contact your healthcare provider for guidance if you need help with what to do. Missing multiple doses can lead to withdrawal symptoms, so it’s important to maintain a consistent dosing schedule and talk to your provider if you’re having trouble staying on track.
Some medications can interact dangerously with buprenorphine and Suboxone, particularly benzodiazepines, alcohol, and other sedatives. Always inform your healthcare provider about all your medications, including over-the-counter drugs and supplements. Your provider will need to review any new medications before you start them to ensure they’re safe to use with your treatment.
Yes, stopping buprenorphine or Suboxone can cause withdrawal symptoms, which is why you should never stop taking them abruptly. When the time is right to discontinue treatment, your healthcare provider will create a tapering plan to reduce your dose over time gradually. This careful tapering helps minimize withdrawal symptoms and gives you the best chance of maintaining recovery. Depending on your current dose and individual needs, the process may take several weeks or months.
[1] Center for Drug Evaluation and Research. (2024). Information about Medications for Opioid Use Disorder (MOUD). FDA. https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud
[2] Brunisholz, K. D., Knighton, A. J., Sharma, A., Nichols, L., Reisig, K., Burton, J., Scovill, D., Tometich, C., Foote, M., Read, S., & Whittle, S. (2020). Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders. Progress in Community Health Partnerships: Research, Education, and Action, 14(1), 43–54. https://pmc.ncbi.nlm.nih.gov/articles/PMC7751497/
[3] Substance Abuse and Mental Health Services Administration. (2024, March 28). Buprenorphine. Www.samhsa.gov. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine
[4] What is Buprenorphine? | UAMS Psychiatric Research Institute. (n.d.). Https://Psychiatry.uams.edu/. https://psychiatry.uams.edu/clinical-care/outpatient-care/cast/buprenorphine/
[5] HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). https://www.suboxone.com/pdfs/prescribing-information.pdf
[6] What is Buprenorphine? | UAMS Psychiatric Research Institute. (n.d.). Https://Psychiatry.uams.edu/. https://psychiatry.uams.edu/clinical-care/outpatient-care/cast/buprenorphine/
[7] Buprenorphine/Naloxone (Suboxone) | NAMI. (n.d.). Www.nami.org. https://www.nami.org/about-mental-illness/treatments/mental-health-medications/types-of-medication/buprenorphine-naloxone-suboxone/
[8] A. Yokell, M., D. Zaller, N., C. Green, T., & D. Rich, J. (2011). Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review. Current Drug Abuse Reviews, 4(1), 28–41. https://pmc.ncbi.nlm.nih.gov/articles/PMC3154701/
[9] Substance Abuse and Mental Health Services Administration. (2024, March 28). Buprenorphine. Www.samhsa.gov. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/buprenorphine
[10] Buprenorphine Sublingual and Buccal (opioid dependence): MedlinePlus Drug Information. (2019, October). Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a605002.html